Indications

Cough suppressant and expectorant in following conditions: acute and chronic bronchitis, chronic respiratory insufficiency, rhinitis, influenzal syndrome, asthma. Acute and chronic coughs.

Present

Blister of 20 film– coated tablets. Box of 2 blisters.

Composition

Eprazinone dihydrochloride……………………………………. 50mg
Excipients s.q. for.……………………………………………..……1 tablet
(Lactose, Pregelatinized starch, Sodium starch glycolate, Sucrose, Magnesium stearate, Colloidal silicon dioxide, Hypromellose, Titanium dioxide, Polyethylene glycol 6000, Polysorbate 80, Talc, Sodium citrate, Citric acid, Erythrosine, Ethanol 96%).

Actions

– Mucolytic and expectorant with respect to the physiology of the mucus, Eprazinone binds to receptor sites of the mucins taking the place of inflammatory proteins.
– Induces eupnea due to its bronchial antispasmodic actions.

Contra-Indications

– History of convulsion.
– Hypersensitivity to any ingredient of the medicine.

Side effect

– Digestive dysfunction may occur such as: stomachache, nausea, diarrhea,…
– Rarely: skin allergy reactions, headache, drowsiness, dizziness.
Inform your doctor about side– effects when using this medicine.

Precaution

– Consider specific therapy for such conditions:
+ Thick expectorate with pus or fever.
+ Lung disease or chronic bronchitis.
– Drivers or operators of machinery.
PREGNANCY AND LACTATION:
– This medicine should be used during pregnancy only when clearly needed.
– Avoid using this medicine for nursing mothers.

Interaction

Do not take concomitantly with other antitussive and expectorant agents.
OVERDOSAGE:
Risk of convulsion. In case of overdosage, management is mainly symptomatic and supportive.

Shelf life

36 months from the manufacturing date.

Storage

Store in a dry place (RH ≤ 70%), not exceeding 30^oC. Protect from light.

Dosage

Adults: 3 – 6 tablets/day in 3 divided doses.
Therapy course should not exceed 5 days unless prescription by your doctor.